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BACKGROUND: Inflammation is a common process in endothelial dysfunction, characterized by an increase in the expression of endothelial cell adhesion molecules
and a decrease of nitric oxide production [1]. Evidence suggests that polyphenols may play a beneficial role in attenuating inflammation with implications on
atherosclerosis [2]. However, their mechanism of action is still not entirely understood due to their poor absorption and extensive intestinal and hepatic transformation [3].
OBJECTIVE: This study aims to evaluate the ability of some gut phenolic metabolites (i.e. protocatechuic, gallic, syringic and vanillic acid; PA, GA, SA, VA,
respectively) to reduce the adhesion of monocytes (THP-1) to endothelial cells (HUVECs), in a stimulated pro-inflammatory environment, and to decrease the production
of cell adhesion molecules (VCAM-1 and E-selectin), as potential markers involved in such modulation.
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METHODS:
RESULTS:
•GA and PA significantly decreased the adhesion of THP-1 to HUVECs at 1 µg
mL-1 (-18.0%; p=0.04 for GA, -29.5%; p=0.03 for PA) and 10 µg mL-1 (-59.3%;
p<0.001 for GA, -44.3%; p=0.001 for PrA) compared to TNF-. VA significantly
reduced the adhesion only at the maximum concentration (-20.8%; p<0.005). No
effect was observed after SA supplementation.
1Data are expressed as mean  SEM. Bars graph with different letters are significantly different (p≤0.05)
GA, gallic acid; PA, protocatechuic acid; SA, syringic acid; VA, vanillic acid
CONCLUSION:
In conclusion, these preliminary results seem to support the capacity of gut phenolic metabolites to modulate the endothelial cell adhesion process. The reduction in the 
adhesion process seems to be driven by a decrease of E-selectin levels but not VCAM-1. Ongoing experiments are attempting to clarify the mechanisms of action of each
compound involved in the above observations.
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• Day 1-Preparation of 96 wells plate (2x104 HUVEC per well);
• Day 2-Labelling of THP-1 cells with CellTrackerTM Green CMFDA,
addition of THP-1 (2x105 cells/well) and TNF- (100 ng mL-1) to HUVEC,
and incubation for 24h;
• Day 3-Incubation with PA, GA, VA and SA at different concentrations (from
0.01 till 10μg mL-1) for 24 h;
• Day 4- Reading of the fluorescence (excitation: 485 nm, emission: 538 nm,
mod. F200 Infinite, TECAN Milan, Italy)
• The levels of vascular cell adhesion molecules (VCAM-1), and endothelial
selectin (E-selectin) were measured in the supernatant by ELISA kits
following the manufacture’s instruction.
• The results derived from three indipendent experiments.
Adhesion of THP-1 to HUVECs
Protocatechuic acid (PA)
Gallic acid (GA) Vanillic acid (VA)
Syringic acid (SA)
Gut phenolic metabolites tested
Evaluation of cell adhesion molecules
Cell viability evaluation
• Cell viability assessed by trypan blue assay
• Cell viability assessed by MTT assay
The viability assay was carried out for each compound (PA, GA, VA and SA) and
for each concentration (from 0.01 till 10μg mL-1). HUVEC were incubated for 24 h
with the compounds and successively, trypan blue assay was performed in
triplicate.
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
tetrazolium reduction assay was performed on HUVECs treated with the maximum
concentration for gut phenolic metabolites. The assay was performed in triplicate
following the instructions reported in the kit.
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1Data are expressed as mean  SEM. Bars graph with different letters are significantly different (p≤0.05)
GA, gallic acid; PA, protocatechuic acid; SA, syringic acid; VA, vanillic acid
• GA and PA significantly decreased the production of E-selectin at 1 µg mL-1 (-
76.6%; p<0.001 for GA, -72.0%; p<0.001 for PA) and 10 µg mL-1 (-77.7%;
p<0.001 for GA, -73.8%; p<0.001 for PA) compared to TNF-. VA
significantly reduced the production of E-selectin only at the maximum
concentration (-65.1%; p<0.005). No effect was detected following SA
supplementation.
• No significant effect was observed on the levels of VCAM-1.
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